Skip to main content
SpringerLink
Log in

Drug-eluting versus bare-metal stents in ST-segment elevation myocardial infarction: a mortality analysis from the EUROTRANSFER Registry

  • Original Paper
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

Abstract

Aim

To assess the patterns of drug-eluting stent (DES) and bare-metal stent (BMS) implantation and associated real-life outcomes in patients with ST-segment elevation myocardial infarction (STEMI) transferred for primary percutaneous coronary intervention (PCI).

Methods

Data were gathered for 1,650 consecutive STEMI patients transferred for primary PCI from hospital networks in seven countries of Europe from November 2005 to January 2007. We identified 1,428 patients with ≥1 stent implanted (86.5%). DES were implanted in 382 patients (26.8%) and BMS in 1,046 patients (73.2%) of 1,428 who received stent.

Results

High variability in DES use among countries participating in the registry (range from 6.8 to 72.1%) was observed. The use of DES in STEMI declined during the fourth quarter of 2006 through the first quarter of 2007. In the assessed population, age, previous PCI, systolic and diastolic pressures on admission, clopidogrel before admission, left anterior descending artery as the infarct-related artery, and thrombus aspiration device use were identified as the independent predictors of DES implantation. Use of DES was associated with significantly lower rates of ischemic events during follow-up (1-year mortality: BMS vs. DES: 6.7% vs. 3.1%; p = 0.014), but observed difference was no longer significant after adjustment for propensity score (adjusted OR (95% CI): 0.55 (0.28–1.06); p = 0.07).

Conclusions

In this large, prospective European registry, the presence of large geographical and temporal variation of DES utilization in STEMI in Europe was confirmed. DES in STEMI appear to be as safe as BMS, with similar mortality after adjustment for potential confounders and trend toward lower 1-year mortality in patients treated with DES.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Stone GW, Lansky AJ, Pocock SJ, Gersh BJ, Dangas G, Wong SC, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Mockel M, Ochala A, Kellock A, Parise H, Mehran R (2009) Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. N Engl J Med 360:1946–1959

    Article  CAS  PubMed  Google Scholar 

  2. Spaulding C, Henry P, Teiger E, Beatt K, Bramucci E, Carrie D, Slama MS, Merkely B, Erglis A, Margheri M, Varenne O, Cebrian A, Stoll HP, Snead DB, Bode C (2006) Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 355:1093–1104

    Article  CAS  PubMed  Google Scholar 

  3. Di Lorenzo E, De Luca G, Sauro R, Varricchio A, Capasso M, Lanzillo T, Manganelli F, Mariello C, Siano F, Pagliuca MR, Stanco G, Rosato G (2009) The PASEO (paclitaxel or sirolimus-eluting stent versus bare metal stent in primary angioplasty) randomized trial. JACC Cardiovasc Interv 2:515–523

    Article  PubMed  Google Scholar 

  4. Brar SS, Leon MB, Stone GW, Mehran R, Moses JW, Brar SK, Dangas G (2009) Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis. J Am Coll Cardiol 53:1677–1689

    Article  PubMed  Google Scholar 

  5. Dibra A, Tiroch K, Schulz S, Kelbaek H, Spaulding C, Laarman GJ, Valgimigli M, Di LE, Kaiser C, Tierala I, Mehilli J, Campo G, Thuesen L, Vink MA, Schalij MJ, Violini R, Schomig A, Kastrati A (2010) Drug-eluting stents in acute myocardial infarction: updated meta-analysis of randomized trials. Clin Res Cardiol 99:345–357

    Article  CAS  PubMed  Google Scholar 

  6. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, Kukreja N, Juni P, Sianos G, Hellige G, Van Domburg RT, Hess OM, Boersma E, Meier B, Windecker S, Serruys PW (2007) Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 369:667–678

    Article  CAS  PubMed  Google Scholar 

  7. Hoffmann R, Klinker H, Adamu U, Kelm M, Blindt R (2009) The risk of definitive stent thrombosis is increased after “off-label” stent implantation irrespective of drug-eluting stent or bare-metal stent use. Clin Res Cardiol 98:549–554

    Article  CAS  PubMed  Google Scholar 

  8. Capodanno D, Capranzano P, Bucalo R, Sanfilippo A, Ruperto C, Caggegi A, Ussia G, Galassi AR, Tamburino C (2009) A novel approach to define risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents: the DERIVATION score. Clin Res Cardiol 98:240–248

    Article  CAS  PubMed  Google Scholar 

  9. Dudek D, Siudak Z, Janzon M, Birkemeyer R, Aldama-Lopez G, Lettieri C, Janus B, Wisniewski A, Berti S, Olivari Z, Rakowski T, Partyka L, Goedicke J, Zmudka K (2008) European registry on patients with ST-elevation myocardial infarction transferred for mechanical reperfusion with a special focus on early administration of abciximab—EUROTRANSFER registry. Am Heart J 156:1147–1154

    Article  CAS  PubMed  Google Scholar 

  10. Rakowski T, Siudak Z, Dziewierz A, Birkemeyer R, Legutko J, Mielecki W, Depukat R, Janzon M, Stefaniak J, Zmudka K, Dubiel JS, Partyka L, Dudek D (2009) Early abciximab administration before transfer for primary percutaneous coronary interventions for ST-elevation myocardial infarction reduces 1-year mortality in patients with high-risk profile. Results from EUROTRANSFER registry. Am Heart J 158:569–575

    Article  CAS  PubMed  Google Scholar 

  11. Siudak Z, Rakowski T, Dziewierz A, Janzon M, Birkemeyer R, Stefaniak J, Partyka L, Zmudka K, Dudek D (2010) Early abciximab use in ST-elevation myocardial infarction treated with primary percutaneous coronary intervention improves long-term outcome. Data from EUROTRANSFER Registry. Kardiol Pol 68:539–543

    PubMed  Google Scholar 

  12. D’Agostino RB Jr (1998) Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17:2265–2281

    Article  PubMed  Google Scholar 

  13. Steg PG, Fox KA, Eagle KA, Furman M, Van de Werf F, Montalescot G, Goodman SG, Avezum A, Huang W, Gore JM (2009) Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the global registry of acute coronary events. Eur Heart J 30:321–329

    Article  PubMed  Google Scholar 

  14. Patel MR, Pfisterer ME, Betriu A, Widmisky P, Holmes DR Jr, O’Neill WW, Stebbins A, Van de Werf F, Armstrong PW, Granger CB (2009) Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study). Am J Cardiol 103:181–186

    Article  PubMed  Google Scholar 

  15. Sianos G, Papafaklis MI, Daemen J, Vaina S, van Mieghem CA, Van Domburg RT, Michalis LK, Serruys PW (2007) Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden. J Am Coll Cardiol 50:573–583

    Article  CAS  PubMed  Google Scholar 

  16. Roe MT, Chen AY, Cannon CP, Rao S, Rumsfeld J, Magid DJ, Brindis R, Klein LW, Gibler WB, Ohman EM, Peterson ED (2009) Temporal changes in the use of drug-eluting stents for patients with non-ST-Segment-elevation myocardial infarction undergoing percutaneous coronary intervention from 2006 to 2008: results from the can rapid risk stratification of unstable angina patients supress ADverse outcomes with early implementation of the ACC/AHA guidelines (CRUSADE) and acute coronary treatment and intervention outcomes network-get with the guidelines (ACTION-GWTG) registries. Circ Cardiovasc Qual Outcomes 2:414–420

    Article  PubMed  Google Scholar 

  17. Camenzind E, Steg PG, Wijns W (2007) Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern. Circulation 115:1440–1455

    Article  PubMed  Google Scholar 

  18. James SK, Stenestrand U, Lindback J, Carlsson J, Schersten F, Nilsson T, Wallentin L, Lagerqvist B (2009) Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden. N Engl J Med 360:1933–1945

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

EUROTRANSFER Registry was an academic research project, which was supported by a research grant from Eli Lilly and Company, Critical Care Europe, Geneva, Switzerland.

Author information

Authors and Affiliations

  1. Second Department of Cardiology, Jagiellonian University Medical College, Krakow, Poland

    Artur Dziewierz, Zbigniew Siudak, Tomasz Rakowski, Waldemar Mielecki, Paweł Ranosz & Jacek S. Dubiel

  2. Department of Interventional Cardiology, Jagiellonian University Medical College, 17 Kopernika St, 31-501, Krakow, Poland

    Dariusz Dudek

  3. Department of Cardiology, Schwarzwald-Baar Klinikum, Villingen-Schwenningen, Germany

    Ralf Birkemeyer

Authors
  1. Artur Dziewierz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zbigniew Siudak
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tomasz Rakowski
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ralf Birkemeyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Waldemar Mielecki
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Paweł Ranosz
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jacek S. Dubiel
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Dariusz Dudek
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dariusz Dudek.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dziewierz, A., Siudak, Z., Rakowski, T. et al. Drug-eluting versus bare-metal stents in ST-segment elevation myocardial infarction: a mortality analysis from the EUROTRANSFER Registry. Clin Res Cardiol 100, 139–145 (2011). https://doi.org/10.1007/s00392-010-0223-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-010-0223-x

Keywords

Search

Navigation